Page 1224 - Basic _ Clinical Pharmacology ( PDFDrive )

1210 Index

Epinephrine reversal, 157 Erythema nodosum leprosum, 850 Estrogen and progesterone inhibitors and
Epinephrine therapy Erythromycin antagonists, 737–740
anaphylaxis treated with, 152–153 acne treated with, 1071 anastrozole, 739
asthma treated with, 350, 362t description of, 819–820, 824t danazol, 738–739
cardiac arrest treated with, 152 prokinetic activity of, 1098 fadrozole, 739
Epirubicin, 965 Erythropoietin (rHuEPO, EPO), 601–602, fulvestrant, 739
Epithelial Na channel (ENaC), 258, 258f 602t, 606t, 997t GnRH and analogs, 739
Eplerenone, 191t, 224t, 717. See also Escalation, dose, 952 letrozole, 739
Aldosterone antagonists; Diuretics Escitalopram, 540t, 542t, 546t, 549t. mifepristone, 738
diuresis using, 265–267, 266t, 273t See also Selective serotonin tamoxifen and related partial agonist
drug interactions of, 1170t–1171t reuptake inhibitors (SSRIs) estrogens, 737f, 737–738
heart failure treated with, 220 Eslicarbazepine (acetate), 417, 433t Estrogen receptors, 707f, 724
Epoetin alfa, 601–602, 602t, 606t Esmolol, 164t, 167. See also b-receptor Estrogen response elements (EREs), 724
Epoprostenol (PGI 2 analog), 324f antagonist drugs Estrone. See also Estrogen(s)
pulmonary hypertension treated with, 335 arrhythmias treated with, 239t–240t, natural, 704f, 722, 723f
structure of, 333f 243, 251t synthetic, 723, 723f
Epothilone-D, 1063 hypertension treated with, 183 Eszopiclone, 382, 383f, 385t, 391, 394t.
Epoxide hydrolases (EHs), 63, 64t Esomeprazole, 1091–1095. See also proton- See also Hypnotics
Epoxyeicosatrienoic acid (EET), 325, 332 pump inhibitors (PPIs) Etanercept
e-prescribing, 1150–1151 Esotropia, accommodative, 118 description of, 993
Eprosartan Essential tremor, 503 psoriasis treated with, 1079
hypertension treated with, 189 Estazolam, 393t. See also Benzodiazepines rheumatic disorders treated with, 654f, 655
on vasoactive peptides, 317t Esters, 61t Ethacrynic acid, for diuresis, 262f, 262t,
Eptifibatide, 621 Estradiol. See also Estrogen(s) 262–264, 273t
Equilenin, 723 natural, 704f, 722, 723f Ethambutol, 842, 843t, 845–846, 851t
Equilibrium potential, 229 synthetic, 723, 723f Ethanol, 382, 396–404, 406t. See also
Equilin, 723 Estriol Sedative-hypnotic drugs
Erectile dysfunction natural, 704f, 722, 723f alcohol use disorder, 396
alpha-receptor antagonists for, 162 synthetic, 723, 723f. See also Estrogen(s) drugs for, 406t, 407t
drugs for, 200b, 211t Estrogen(s), 722–727. See also specific types antisepsis and disinfection uses of, 898,
Erection, penile, 344 adverse effects of, 726–727 898t
Erethism, 1028 on bone homeostasis, 779 clinical pharmacology of, 402–404
Ergocalciferol, 789t. See also Vitamin D clinical uses of acute alcohol intoxication, 402–403
Ergoline, 292 hypogonadism, primary, 725 alcoholism, 404, 406t, 407t
Ergonovine, 294–295, 297t. See also Ergot ovulation suppression, 726 alcohol withdrawal syndrome, 403,
alkaloids postmenopausal hormonal therapy, 403f, 406t, 407t, 585, 589t
Ergosterol, 854 725–726 dependence on, 396, 400
Ergot alkaloids, 292–296, 297t–298t contraindications to, 727 drug interactions, 402, 1157t
accidental ingestion of, 292 drug interactions of, 1166t in OTC agents, 1129t
applications of natural, 722f, 722–723 pharmacodynamics of, 398–402
hyperprolactinemia, 295 pharmacokinetics of, 723–724 in acute consumption, 398t, 398–399
migraine, 295 physiologic effects of, 724–725 alcohol-drug interactions in, 402
postpartum hemorrhage, 295 blood coagulation, 725 animal research on, 399b
senile cerebral insufficiency, 295 edema, 725 chronic consumption, 399–402
variant angina diagnosis, 295 endometrial, 724 cancer risk, 402
chemistry and pharmacokinetics of, female maturation, 724 cardiovascular system, 401
292–293, 293t mechanism of action in, 707f, 724 endocrine system and electrolyte
origins of, 292 metabolic and cardiovascular, balance, 401
pharmacodynamics of, 293t, 293–295, 724–725 fetal alcohol syndrome, 401
294f progesterone receptor synthesis, immune system, 402
preparations available, 297t–298t 725 liver and GI tract effects, 399–400
Ergotamine, 160, 294–295, 297t stress system, 725 nervous system, 400–401
Ergotism, 292, 292b sympathetic nervous system, 725 poisoning with, 396, 408, 1045
Ergotropic nervous system, 100 preparations and dosages of, 724t, 727, prevalence of use, 396
Eribulin, 963–964 745t tolerance and dependence on, 396, 400
Erlotinib, 966t, 968 synthetic, 723, 723f withdrawal syndrome management for, 403
Errors, prescribing, 1148–1149 types of, 722–723 drugs in, 406t, 407t, 585, 589t
Ertapenem, 803t, 807, 812t Estrogen agonists, 737f, 737–738 time course of, 403f